During the past decade, Latvian American Eye Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Latvian American Eye Center" #1 collaborator was "Regeneron Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Latvian American Eye Center" are "Diabetic Macular Edema" (1 trials), "Macular Edema" (1 trials), "Neovascular Age-Related Macular Degeneration" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Latvian American Eye Center" in a lesser frequency.

Most popular intervention types in "Latvian American Eye Center" are "Drug" (3 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (2 trials), "KSI-301" (2 trials), "Sham Procedure" (2 trials), "Aflibercept High Dose VEGF Trap-Eye (BAY86-5321)" (1 trials) and "Aflibercept VEGF Trap-Eye (Eylea, BAY86-5321)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Latvian American Eye Center" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Latvian American Eye Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Latvian American Eye Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Latvian American Eye Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".